Back to search
Generalized Epidermolysis Bullosa Simplex
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Generalized Epidermolysis Bullosa Simplex trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Generalized Epidermolysis Bullosa Simplex trials you may qualify forThis Phase II clinical study will assess the efficacy, safety and tolerability of topical TolaSure Gel in adults and pediatric patients (4 years of age and olde…
The goal of this clinical trial is to Assessing the Efficacy and Safety of Apremilast in Patients \> 6 years of age with EB simplex generalized . The main quest…
The proposed Phase 2/3 trial with double-blind and open-label extension phases is an international, multicenter study designed to assess the efficacy and safety…
Epidermolysis bullosa (EB) simplex is a rare orphan disease caused by a mutation in DNA leading to abnormal dominant keratins in the skin. Patients with EB simp…